
Dasatinib for Cancer a Potential Alzheimer’s Drug
RESEARCH & TREATMENT: Researchers find an experimental drug for liver cancer and Dasatinib, approved for chronic myeloid leukemia, act upon some Alzheimer’s disease related proteins
RESEARCH & TREATMENT: Researchers find an experimental drug for liver cancer and Dasatinib, approved for chronic myeloid leukemia, act upon some Alzheimer’s disease related proteins
OLD-NEW DRUG RESEARCH: The diuretic bumetanide, used for more than 30 years to treat hypertension and heart failure, was also found to reverse signs of
RESEARCH: Researchers say that a drug commonly used to treat cancer can restore memory and cognitive function in mice with symptoms of Alzheimer’s. Learn more.
BREAKTHROUGH: The US Food and Drug Administration (FDA) has granted a “Breakthrough Therapy” designation for donanemab, a potential new treatment for people with early symptomatic
BREAKTHROUGH & TREATMENT: The new Alzheimer’s drug aducanumabab (Aduhelm) has received accelerated approval by the US Food and Drug Administration. Why did it take so
VIDEO + ARTICLE: Scientists are applying an FDA-approved technique, Deep Brain Stimulation, to treat mild Alzheimer’s for 150 patients in Phase-3 clinical trials. Learn more.
MEDICATION TRIALS: The FDA has accepted Biogen’s application for aducanumab, an investigational treatment for Alzheimer’s, and even granted it Priority Review, with an action date
DIAGNOSIS NEWS: Scientists at Lund University are working on a new blood test that not only can diagnose Alzheimer’s already in progress, but in persons
In some cases, COVID-19 patients may present with neurological symptoms. Having an MRI while at the hospital, as well as monitoring after hospitalization, are important
A GREAT DENTAL resource provides low-cost programs for American seniors. Also check out the website’s free “how to” guide for communities.
DIET VIDEO:
Why the big rise in Alzheimer’s? That is one of today’s great medical mysteries.
See a provocative theory about copper & Alzheimer’s in The Journal of the American College of Nutrition.
If you couldn’t see your mashed potatoes, you probably wouldn’t eat them. That’s why what “The Red Plate Study” found was astonishing! Alzheimer’s patients eating from red plates consumed 25 percent more food than those eating from white plates. Find out why.
Learn about 2025’s newly approved or potential Alzheimer’s drugs. These include Leqembi, Kisunla, Remternetug, Semaglutide, Trontinemab and Bepranemab.
Three important dementia studies focus on HS-AGING, a type of dementia almost as common as Alzheimer’s in the 85+ group. Yet few people have heard of it. Why? What makes it different?
An intriguing study of 120 grandmothers might surprise you. Doctors know socially engaged people have better cognition and less dementia. But can a person get too much of a good thing? What’s the right balance?
Enjoy this great duet between a musician with dementia and his son. A triumph of spirit over Alzheimer’s! Sing-a-long if you like!
It looks like a sneeze cannot give anyone Alzheimer’s. While Alzheimer’s abnormal disease proteins do spread from cell-to-cell, they are not “infectious”. Check out the facts.
No spam, only news and updates.